Quality-of-Life Assessment in Comparative Therapeutic Trials and Causal Structure Considerations in Peripheral Occlusive Arterial Disease

Author： Lehert P.

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.2, 2001-01, pp. : 121-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Options in the Treatment of Multiple Myeloma: Pharmacoeconomic and Quality-of-Life Considerations

By Wisløff F.

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 329-341

Adis International

Access to resources Recommend Favorite

Generic Health-Related Quality-of-Life Assessment in Children and Adolescents: Methodological Considerations

By Ravens-Sieberer Ulrike Erhart Michael Wille Nora

PharmacoEconomics, Vol. 24, Iss. 12, 2006-01 ,pp. : 1199-1220

Adis International

Access to resources Recommend Favorite

Systemic antiatherosclerotic treatment for the peripheral arterial occlusive disease patient

By Baumgartner Iris

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2181-2192

Informa Healthcare

Access to resources Recommend Favorite

Quality-of-Life Assessment in Rheumatoid Arthritis

By Russell Anthony S.

PharmacoEconomics, Vol. 26, Iss. 10, 2008-01 ,pp. : 831-846

Adis International

Access to resources Recommend Favorite

A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials

By Clayson Darren J.

PharmacoEconomics, Vol. 24, Iss. 8, 2006-01 ,pp. : 751-765

Adis International

Access to resources Recommend Favorite